Pacer BioThreat Strategy ETF
VIRS
VIRS was delisted on the 10th of October, 2024.
4 hedge funds and large institutions have $1.34M invested in Pacer BioThreat Strategy ETF in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
28% less capital invested
Capital invested by funds: $1.87M → $1.34M (-$521K)
33% less funds holding
Funds holding: 6 → 4 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$33.9K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$667K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$9.87K |
| 3 |
Morgan Stanley
New York
|
-$48 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $838K | -$9.87K | -259 | -1% |
|
2
Osaic Holdings
Scottsdale,
Arizona
| $359K | – | – | – |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $109K | +$5.38K | +141 | +5% |
|
|
4
UBS Group
Zurich,
Switzerland
| $38.8K | +$33.9K | +890 | +1,060% |
|
|
IAIM
5
International Assets Investment Management
Orlando,
Florida
| – | -$667K | -18,355 | Closed |
|
|
6
Morgan Stanley
New York
| – | -$48 | -1 | Closed |
|
VIRS Hedge Fund Activity: Q3 2024 in Review
4 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Pacer BioThreat Strategy ETF (VIRS) for Q3 2024, worth a combined $1.34M — down 28% from $1.87M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of VIRS and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $33.9K. The largest seller was International Assets Investment Management, exiting entirely with an estimated $667K sold.
- 4 institutional investors held Pacer BioThreat Strategy ETF (VIRS) as of Q3 2024, down from 6 in Q2 2024.
- Funds reported $1.34M of Pacer BioThreat Strategy ETF stock for Q3 2024, down 28% quarter-over-quarter.
- 0 funds opened new Pacer BioThreat Strategy ETF positions in Q3 2024 and 2 closed out, a net change of -2 holders.
- The largest Pacer BioThreat Strategy ETF buyer in Q3 2024 was UBS Group, an estimated $33.9K added.
- The largest Pacer BioThreat Strategy ETF seller in Q3 2024 was International Assets Investment Management, an estimated $667K sold.
Based on aggregated 13F filings for Q3 2024.